Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

38381 - 38390 of 44782 results found

COVID-19 Vaccine Safety First Year Findings in Adolescents

Date
Friday, April 21, 2023 - 4:00 AM
Description
CONCLUSIONS: During the first year BNT-162b2 was administered to adolescents ages 12 to 17 years, most reported adverse events were mild and appeared self-limited. Rates of myocarditis were lower than earlier reports. No new serious safety concerns